MedPath

Elmedix

🇧🇪Belgium
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Safety Study of Whole Body Hyperthermia for Advanced Cancer

Not Applicable
Completed
Conditions
Advanced Cancer
Pancreatic Cancer Metastatic
Interventions
Device: Whole body hyperthermia
Drug: Standard of Care (SOC) chemotherapy according to the NCCN guidelines.
First Posted Date
2020-07-13
Last Posted Date
2025-08-05
Lead Sponsor
ElmediX
Target Recruit Count
16
Registration Number
NCT04467593
Locations
🇧🇪

University Hospital Antwerp, Edegem, Antwerpen, Belgium

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.